Journals / Osteoporoz Dünyasından / 2004 / Cilt: 10 - Sayı: 2

The comparsion of bone mineral density, D vitamin levels and other laboratory parameters in postmenopausal women

Postmenopozal kadınlarda kemik mineral yoğunluğu ile D vitamini ve diğer laboratuvar değerlerin karşılaştırılması

Pages
70–73
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

A weak linear correlation was present between BF and BMD.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Forty-eight postmenopausal women, selected among the patients who applied to our outpatient physical medicine and rehabilitation department without previous osteoporosis medication, were separeted into 3 groups according to bone mineral density (BMD) values as normal, osteopenic and osteoporotic.
📊
Key Findings & Data:Linear correlations were found respectively between 25(OH) D vitamin and PTH, 25(OH) D vitamin and phosphor (p = 0.009), 1,25(OH)2 Ü3 and bone formation (BF) was found (r = 0.03, p = 0.02) while there was negative correlation with bone resorption (BR) (r = -0.31, p = 0.01).
💡
Conclusion & Impact:A weak linear correlation was present between BF and BMD.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Kemik yoğunluğu · Postmenopoz · Kadınlar

Abstract

Forty-eight postmenopausal women, selected among the patients who applied to our outpatient physical medicine and rehabilitation department without previous osteoporosis medication, were separeted into 3 groups according to bone mineral density (BMD) values as normal, osteopenic and osteoporotic. The correlations between demographic properties, menopause duration and laboratory parameters were investigated. Linear correlations were found respectively between 25(OH) D vitamin and PTH, 25(OH) D vitamin and phosphor (p = 0.009), 1,25(OH)2 Ü3 and bone formation (BF) was found (r = 0.03, p = 0.02) while there was negative correlation with bone resorption (BR) (r = -0.31, p = 0.01). In osteoporosis group, there was a negative correlation between 25(OH) D vitamin and BF (r = -0.45, p = 0.04). Additionally, there was a si-miliar correlation between 1,25(OH)2 D3 vitamin and 1,25(OH)2 D3 to BF, BR and % loss of BMD in normal and osteopenic groups. A weak linear correlation was present between BF and BMD.

Özet

Trakya Üniversitesi Tıp Fakültesi Fiziksel Tıp ve Rehabilitasyon Anabilim Dalı Polikliniğine başvuran postmenöpozal olgular arasında hiç tedavi görmemiş olan 48 kadın, KMY değerlerine göre normal, osteopenik ve östeoporo-tik olarak 3 gruba ayrıldı. Olguların demografik özellikleri, menopoz süreleri ve laboratuar parametreleri araştırıldı. Gruplarda, 25(OH) D vitamini ve" PTH (r = 0.80, p = 0,009) 25(OH) D vitamini ve fosfor (p = 0,03, r = -0.70), 1,25(OH)2 D3 vitamini KALP (p = 0.001) arasında doğrusal bir ilişki olduğu saptandı. Normal KMY gösteren olgularda 1,25(OH)2 D3 ile kemik formasyonu (KF) arasında pozitif doğrusal (r = 0.30, p = 0.02), 1,25(OH)2 D3 ile kemik rezorpsiyonu (KR) arasında negatif korelas-yon(r,,= -0.91, p = 0.01) saptandı. Osteoporoz grubunda 25(OH) D vit ve KF (r = -0.45, p = 0.04) arasında ve aynı şekilde 1,25(OH)3 D3 ve KR arasında negatif korelasyon (r = -0.48, p = 0,03) gözlendi. Normal ve osteopenik olgularda KMY ve KF arasında zayıf doğrusal korelasyon gözlenirken serum 25(OH) D ve 1,25(OH)2 D3 ile KF, KR ve %KMY kayıpları arasında bir korelasyon saptanmadı.

🔖

Cite This Article

KOKİNO, S., PEKİNDİL, Y., HAKGÜDER, A., YILDIZ, M. (2004). The comparsion of bone mineral density, D vitamin levels and other laboratory parameters in postmenopausal women. Osteoporoz Dünyasından, Cilt: 10 - Sayı: 2, 70–73. https://ajindex.com/articles/286834

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Oral A: Osteoporozda yeni tedavi seçenekleri. Lokomotor 1997; 1(4): 43-8 2. Mathieu C, Adorini L:The coming on age of 1.25 dihydroxyvitamin D3 analogs as immunomodulatory agents trend. Molecular Medicine. 2002; 8(4):174-8. 3. Alagöl F: D vitamini: 1.Ulusal Osteoporoz Kongresi, 7-11 Ekim Antalya 2002 (özet kitabı) 4. Ardıçoğlu Ö: D vitamini metabolizması. Osteoporozda Tanı ve Tedavi.Turgut Göksoy(Ed). İstanbul, 2000; 53-8. 5. Arasıl T, Yavuzer G: Osteoporozda aktif D metabolitleri. Osteoporozda Tanı ve Tedavi. Turgut Göksoy(Ed), 2000;319-324. 6. Heaney RP: Vit D. How much do we need and how much is too much?. Osteop Int. 2000; 11;553-55. 7. Grados F, Brazier M, Kamel S, Duver S. Effet sur la densite minerale osseuse d’une supplementation, vitamino calcique chez la femme ag_e presentant une ınsuffısance en vitamin D. Reuve du Rhumatisme 2003; 70:4008-415. 8. Thomas MK, Jones DM, Thadhani RI: Hipovitaminosis D in medikal in patients. N Engl J Med. 1998; 338(12):777-83. 9. Gomez C, Naves ML, Fernandes JL. Are the serum vitamin D cut off levels enough to avoid the development. 10th World Congress on Osteoporosis. Lisbon-Portugal,10-14 May 2002. 10. Delle SA, Mazantini M, Frigelli S, et all: 10th World Congress on Osteoporozis.Lisbon-Portugal,10-14 May 2002. 11. Trivelle, Sebog R, Guillement S. Prevention et traitment d’insuffissance en vitamin D du sujet âge: Reuve Med Intane 1999; 20:755-8. 12. Akyüz G: Kalsiyum ve D vitaminlerinin kemik kalitesine etkisi. Osteoporoz ve Kemik Kalitesi Semp., 25-29 Haz 2003; (özet kitabı). 13. Ushiroyama T, Ikeda A, Yeki M. Effect of continuous combined therapy with vit D2 and Vit D3 on bone mineral density in postmenopausal women. Matirutas 2002; 41(3):211-221. 14. Guillilement S, Hat YL, Maria A et al. Wintertime and vitamin D deficiency in male adolescents. Osteoporosis Int 2001; 12: 875-99. 15. Dinç A, Eryavuz M. Osteoporoz ve diyet. Osteoporoz Dünyasından 2002; 8: 89-93.